A detailed history of State Of Tennessee, Treasury Department transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 742,833 shares of BMY stock, worth $39.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
742,833
Previous 813,084 8.64%
Holding current value
$39.5 Million
Previous $44.1 Million 30.04%
% of portfolio
0.12%
Previous 0.17%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $2.83 Million - $3.72 Million
-70,251 Reduced 8.64%
742,833 $30.8 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $301,170 - $341,468
-6,277 Reduced 0.77%
813,084 $44.1 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $30.2 Million - $36 Million
-622,766 Reduced 43.18%
819,361 $42 Million
Q2 2023

Aug 15, 2023

BUY
$63.71 - $70.74 $19.7 Million - $21.9 Million
309,208 Added 27.29%
1,442,127 $92.2 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $8.26 Million - $9.37 Million
125,656 Added 12.47%
1,132,919 $78.5 Million
Q4 2022

Feb 15, 2023

SELL
$68.48 - $81.09 $23.9 Million - $28.3 Million
-349,472 Reduced 25.76%
1,007,263 $72.5 Million
Q3 2022

Jan 26, 2023

BUY
$0.13 - $76.84 $3,250 - $1.92 Million
25,000 Added 1.88%
1,356,735 $96.5 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $16.8 Million - $18.5 Million
-231,870 Reduced 14.83%
1,331,735 $103 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $16.7 Million - $20.1 Million
272,050 Added 21.06%
1,563,605 $114 Million
Q4 2021

Feb 15, 2022

SELL
$53.63 - $62.52 $11.2 Million - $13 Million
-208,400 Reduced 13.89%
1,291,555 $80.5 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $7.82 Million - $9.16 Million
-132,188 Reduced 8.1%
1,499,955 $88.8 Million
Q2 2021

Aug 11, 2021

SELL
$61.91 - $67.42 $16.1 Million - $17.6 Million
-260,763 Reduced 13.78%
1,632,143 $109 Million
Q1 2021

May 10, 2021

BUY
$59.34 - $66.74 $22.8 Million - $25.7 Million
384,702 Added 25.51%
1,892,906 $119 Million
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $50.7 Million - $57.5 Million
878,388 Added 139.47%
1,508,204 $93.6 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $80.7 Million - $89.4 Million
-1,404,634 Reduced 69.04%
629,816 $38 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $585,751 - $684,801
10,685 Added 0.53%
2,034,450 $120 Million
Q1 2020

May 28, 2020

BUY
$46.4 - $67.43 $25.6 Million - $37.2 Million
551,144 Added 37.43%
2,023,765 $113 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $14.1 Million - $20.5 Million
-304,568 Reduced 17.14%
1,472,621 $82.1 Million
Q4 2019

Feb 06, 2020

BUY
$49.21 - $64.19 $42.4 Million - $55.3 Million
861,233 Added 94.03%
1,777,189 $114 Million
Q3 2019

Oct 30, 2019

SELL
$42.77 - $50.71 $19.7 Million - $23.4 Million
-460,970 Reduced 33.48%
915,956 $46.4 Million
Q2 2019

Aug 12, 2019

BUY
$44.62 - $49.34 $43.2 Million - $47.8 Million
968,399 Added 237.05%
1,376,926 $62.4 Million
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $4.86 Million - $5.79 Million
-107,690 Reduced 20.86%
408,527 $19.5 Million
Q4 2018

Feb 11, 2019

SELL
$48.76 - $63.23 $48.6 Million - $63 Million
-996,913 Reduced 65.88%
516,217 $26.8 Million
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $15.6 Million - $17.6 Million
283,006 Added 23.01%
1,513,130 $93.9 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $6.71 Million - $8.36 Million
132,786 Added 12.1%
1,230,124 $68.1 Million
Q1 2018

May 11, 2018

SELL
$59.92 - $68.98 $24.4 Million - $28.1 Million
-407,931 Reduced 27.1%
1,097,338 $69.4 Million
Q4 2017

Feb 12, 2018

BUY
$59.94 - $65.35 $9.2 Million - $10 Million
153,527 Added 11.36%
1,505,269 $92.2 Million
Q3 2017

Nov 01, 2017

BUY
$55.23 - $63.74 $74.7 Million - $86.2 Million
1,351,742
1,351,742 $86.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track State Of Tennessee, Treasury Department Portfolio

Follow State Of Tennessee, Treasury Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.